High-performance liquid chromatography interfaced with inductively coupled plasma mass spectrometry, and hydride generation-inductively coupled plasma mass spectrometry were used, respectively, to investigate changes in both the chemical form and the concentration of selenium during its bio-incorporation and bio-accumulation into rye seedlings. A 60-fold increase in the total level of selenium in the seedlings ('control' biomass = 0.99 mg kg(-1), 'enriched' biomass = 55.27 mg kg(-1)) was accompanied by a change from selenite to several organo-selenium forms, with more than 40% being present as selenomethionine. The seedling biomass was dried, ground and used as an ingredient in the production of a fermented sourdough bread (popular in Poland and many Eastern European countries). The selenium in the resulting bread was also characterized in terms of its speciation, as well as its total selenium content ('control' bread = 0.06 mg kg(-1), 'enriched' bread = 3.56 mg kg(-1)). The breads were then fed to 24 volunteers as part of a human intervention study designed to establish the efficacy of this mode of selenium supplementation. The human study data subsequently showed the bread was a good source of dietary selenium.
This study examined the effects of arsenic exposure and the biotransformation capacity of developing Iberian green frogs (Rana perezi) with the main aim of finding valid biomarkers to monitor pollution and toxicological problems. Total arsenic concentration and arsenic species distribution were determined using liquid chromatography coupled with inductively coupled plasma-mass spectrometry (LC-ICP-MS). The level of accumulation of arsenic and its species distribution differed depending on the metamorphosis stage and level of exposure. Tetramethylarsonium cation was the major compound detected and continuously increased in concentration during frog development. Results suggest that rather low As accumulation is obtained and that Rana perezi metabolised arsenic during embryonic and larval development.
Iron deficiency is the most prevalent mineral deficiency in the world. Food fortification offers an alternative to standard oral iron therapy, which often causes unpleasant side effects. In this study, bread was fortified with either ferrous sulphate or ferrous fumarate. To prevent undesired organoleptic changes in colour, odour and taste, iron compounds were introduced in the form of microcapsules. Eight types of bread were prepared using conventional fermentation or sourdough and fortified with one of four types of microcapsule. The in vitro bioaccessibility and bioavailability of the iron were determined using the human epithelial adenocarcinoma cell line Caco-2, preceded by digestion in a dynamic gastrointestinal digester, which mimics the upper gastrointestinal tract of an adult human. The bioaccessibility of the iron after digestion of the fortified breads varied from 41.45 to 99.31%. The iron transport efficiency varied widely, from 1.16 to 13.78%. Generally, both bioaccessibility and transport efficiency were higher in the samples of breads prepared by conventional fermentation. The mRNA expression of DMT1 and IREG1, cellular iron transporters which serve as molecular markers of iron movement across the intestinal border, was not statistically significant.
The immune response of wheat flour modified by the treatment with transglutaminase under different conditions of temperature, incubation periods and the ratio of enzyme/wheat flour was investigated. The particular wheat protein fractions were examined for the immune reaction by the use of an indirect non-competitive ELISA. Commercially available antibodies, namely, monoclonal antihuman IgG and monoclonal antihuman IgE conjugates with alkaline phosphatase and human sera with elevated IgG as well as rabbit sera against QQQPP peptide were tested. The highest decrease in gliadins immunoreactivity was observed for wheat flour modified under following conditions: temperature 378C, 18 h of incubation and the ratio enzyme/wheat flour 1:10 000. For all rabbit sera examined the residual immunoreactivity of glutenins was found to be below 30% of the level measured for the untreated protein. The large decrease in allergenicity of glutenins leads to the conclusion that wheat flour modified by treatment with transglutaminase may be used as a constituent of food products destined for people with a classic food allergy, i.e. the allergy elicited by that protein fraction.
The aim of this study was to investigate the influence of oral iron supplementation, in the form of fortified breads, on the growth performance, health, iron status parameters, and fecal metabolome of anemic piglets. A study was conducted on 24 hybrid (Large White × Landrace × Duroc) piglets. From day 44, the post-natal 12 piglets were supplemented with 100 g of one of two experimental breads, each fortified with 21 mg of ferrous sulphate, either encapsulated or not. After one week of oral supplementation, hematological parameters (hematocrit value, hemoglobin, and red blood cells) showed statistically significant differences (p ≤ 0.05). Piglets fed with the fortified breads had higher iron concentrations in the heart, liver, and intestinal mucosa compared to anemic piglets fed with control bread. Gene expression of hepcidin, iron exporter ferroportin (IREG1), and divalent metal transporter 1 (DMT1), together with concentrations of plasma ferritin, showed no significant statistical differences between groups. Both fortified breads could be used as sources of bioavailable iron. The seven-day intervention trial showed microencapsulation to have only a mild effect on the effectiveness of iron supplementation in the form of fortified bread.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.